GANDELLINI, PAOLO
 Distribuzione geografica
Continente #
EU - Europa 2.178
NA - Nord America 2.105
AS - Asia 1.273
OC - Oceania 27
SA - Sud America 14
AF - Africa 12
Continente sconosciuto - Info sul continente non disponibili 1
Totale 5.610
Nazione #
US - Stati Uniti d'America 2.076
DE - Germania 674
CN - Cina 646
GB - Regno Unito 490
IT - Italia 382
SG - Singapore 222
SE - Svezia 175
IN - India 130
HK - Hong Kong 101
IE - Irlanda 99
RU - Federazione Russa 93
DK - Danimarca 75
FR - Francia 58
ID - Indonesia 41
VN - Vietnam 32
JP - Giappone 29
KR - Corea 27
AU - Australia 26
UA - Ucraina 22
CA - Canada 21
FI - Finlandia 18
NO - Norvegia 16
TW - Taiwan 14
BE - Belgio 13
NL - Olanda 13
PL - Polonia 13
CH - Svizzera 8
AT - Austria 6
MX - Messico 6
BR - Brasile 5
CO - Colombia 5
ES - Italia 5
IR - Iran 5
MM - Myanmar 5
MY - Malesia 5
SC - Seychelles 5
BD - Bangladesh 4
CL - Cile 4
PT - Portogallo 4
TR - Turchia 4
CZ - Repubblica Ceca 3
EG - Egitto 3
BA - Bosnia-Erzegovina 2
BG - Bulgaria 2
GR - Grecia 2
SA - Arabia Saudita 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AL - Albania 1
BZ - Belize 1
DO - Repubblica Dominicana 1
EE - Estonia 1
EU - Europa 1
FJ - Figi 1
HR - Croazia 1
HU - Ungheria 1
IL - Israele 1
IQ - Iraq 1
KE - Kenya 1
MO - Macao, regione amministrativa speciale della Cina 1
OM - Oman 1
PH - Filippine 1
PK - Pakistan 1
RO - Romania 1
TN - Tunisia 1
ZA - Sudafrica 1
ZW - Zimbabwe 1
Totale 5.611
Città #
Frankfurt am Main 567
Southend 348
Fairfield 271
Chandler 223
Milan 176
Houston 148
Singapore 136
Wilmington 126
Ashburn 124
Woodbridge 120
Seattle 113
Princeton 103
Dublin 99
Beijing 96
Cambridge 93
Ann Arbor 78
Nanjing 65
Dearborn 58
Boardman 45
Hong Kong 45
Phoenix 42
Shanghai 37
Des Moines 36
Jakarta 36
Bengaluru 31
Central District 31
Shenyang 28
Guangzhou 26
Dong Ket 22
Berlin 19
Jinan 19
Redwood City 19
Changsha 17
Hebei 17
San Diego 16
Chengdu 15
Santa Clara 15
London 13
Nanchang 13
Tianjin 13
Wuhan 13
Los Angeles 11
Mountain View 11
Seoul 11
Catania 10
Gdansk 10
Hangzhou 10
Madison 10
Taipei 10
Xian 10
Brussels 9
Jacksonville 9
New York 9
Zhengzhou 9
Helsinki 8
Jiaxing 8
Ningbo 8
Grafing 7
Tokyo 7
Toronto 7
Bühl 6
Chicago 6
Costa Mesa 6
Florence 6
Hackney 6
Hefei 6
Kent 6
Kunming 6
Nottingham 6
Rome 6
Silver Spring 6
Taiyuan 6
Bogotá 5
Eitensheim 5
Evanston 5
Forlimpopoli 5
Fuzhou 5
Harbin 5
Kilburn 5
Limbiate 5
Mahé 5
Miami 5
Munich 5
New Delhi 5
Newcastle 5
Philadelphia 5
Pittsburgh 5
San Gimignano 5
Taizhou 5
Bergamo 4
Birmingham 4
Haikou 4
Hyderabad 4
Kochi 4
Lanzhou 4
Lappeenranta 4
Latrobe 4
Lecco 4
Mymensingh 4
Nantes 4
Totale 3.887
Nome #
Reciprocal Metabolic Reprogramming through Lactate Shuttle Coordinately Influences Tumor-Stroma Interplay 416
LEADeR role of miR-205 host gene as long noncoding RNA in prostate basal cell differentiation 283
miR-205 exerts tumor-suppressive functions in human prostate through down-regulation of protein kinase C epsilon 282
MiR-205 enhances radiation sensitivity of prostate cancer cells by impairing DNA damage repair through PKCϵ and ZEB1 inhibition 225
Core Biopsies from Prostate Cancer Patients in Active Surveillance Protocols Harbor PTEN and MYC Alterations 214
Splicing modulation as novel therapeutic strategy against diffuse malignant peritoneal mesothelioma 168
miR-21: an oncomir on strike in prostate cancer 164
SPOP deregulation improves the radiation response of prostate cancer models by impairing DNA damage repair 163
Biological relevance and therapeutic potential of G-quadruplex structures in the human noncoding transcriptome 162
Predicting and Understanding Cancer Response to Treatment 152
Large oncosomes mediate intercellular transfer of functional microRNA 145
Antitumor activity of miR-34a in peritoneal mesothelioma relies on c-MET and AXL inhibition : persistent activation of ERK and AKT signaling as a possible cytoprotective mechanism 138
Coated cationic lipid-nanoparticles entrapping miR-660 inhibit tumor growth in patient-derived xenografts lung cancer models 137
Anti-tumor activity of selective inhibitors of XPO1/CRM1-mediated nuclear export in diffuse malignant peritoneal mesothelioma : the role of survivin 132
Integrated gene and miRNA expression analysis of prostate cancer associated fibroblasts supports a prominent role for interleukin-6 in fibroblast activation 130
miR-205 regulates basement membrane deposition in human prostate: implications for cancer development 124
MiR-205 impairs the autophagic flux and enhances cisplatin cytotoxicity in castration-resistant prostate cancer cells 124
MiR-205 hinders the malignant interplay between prostate cancer cells and associated fibroblasts 122
Gene expression dataset of prostate cells upon MIR205HG/LEADR modulation 122
miR-1272 Exerts Tumor-Suppressive Functions in Prostate Cancer via HIP1 Suppression 121
Prediction of grade reclassification of prostate cancer patients on active surveillance through the combination of a three-mirna signature and selected clinical variables 115
Apollon gene silencing induces apoptosis in breast cancer cells through p53 stabilisation and caspase-3 activation 104
miR-380-5p-mediated repression of TEP1 and TSPYL5 interferes with telomerase activity and favours the emergence of an "ALT-like" phenotype in diffuse malignant peritoneal mesothelioma cells 103
Unveiling the ups and downs of miR-205 in physiology and cancer: transcriptional and post-transcriptional mechanisms 102
Targeting the telosome: Therapeutic implications 95
Mesenchymal to amoeboid transition is associated with stem-like features of melanoma cells 95
Complexity in the tumour microenvironment : cancer associated fibroblast gene expression patterns identify both common and unique features of tumour-stroma crosstalk across cancer types 92
Clusterin: A potential target for improving response to antiestrogens 92
Noncoding RNAs in the interplay between tumor cells and cancer-associated fibroblasts: Signals to catch and targets to hit 85
MicroRNAs in Cancer Management : Big Challenges for Small Molecules 80
miR-875-5p counteracts epithelial-to-mesenchymal transition and enhances radiation response in prostate cancer through repression of the EGFR-ZEB1 axis 75
Potential of the Stromal Matricellular Protein Periostin as a Biomarker to Improve Risk Assessment in Prostate Cancer 73
miRNAs in tumor radiation response : bystanders or participants? 61
Dissecting the role of microRNAs in prostate cancer metastasis : implications for the design of novel therapeutic approaches 61
Emerging Role of microRNAs in Prostate Cancer: Implications for Personalized Medicine 54
Oligomer-mediated modulation of hTERT alternative splicing induces telomerase inhibition and cell growth decline in human prostate cancer cells 53
Targeting MicroRNAs to withstand cancer metastasis 52
MicroRNAs and the Response of Prostate Cancer to Anti-Cancer Drugs 52
Navigating the Multiverse of Antisense RNAs: The Transcription- and RNA-Dependent Dimension 50
MicroRNA-dependent Regulation of Telomere Maintenance Mechanisms: A Field as Much Unexplored as Potentially Promising 48
microRNAs as players and signals in the metastatic cascade : implications for the development of novel anti-metastatic therapies 47
RNA Interference-Mediated Validation of Survivin and Apollon/BRUCE as New Therapeutic Targets for Cancer Therapy 47
MicroRNAs: Cobblestones on the road to cancer metastasis 45
PKC-alpha modulation by miR-483-3p in platinum-resistant ovarian carcinoma cells 45
Senescent stroma promotes prostate cancer progression : the role of miR-210 45
Coding the noncoding: 2 years of advances in the field of microRNAs and long noncoding RNAs 45
Antisense oligonucleotide-mediated inhibition of hTERT, but not hTERC, induces rapid cell growth decline and apoptosis in the absence of telomere shortening in human prostate cancer cells 44
MicroRNA-Mediated Control of Prostate Cancer Metastasis: Implications for the Identification of Novel Biomarkers and Therapeutic Targets 44
Down-regulation of human telomerase reverse transcriptase through specific activation of RNAi pathway quickly results in cancer cell growth impairment 39
MIR205HG/LEADR Long Noncoding RNA Binds to Primed Proximal Regulatory Regions in Prostate Basal Cells Through a Triplex- and Alu-Mediated Mechanism 37
The pancancer overexpressed NFYC Antisense 1 controls cell cycle mitotic progression through in cis and in trans modes of action 36
Towards the definition of prostate cancer-related microRNAs: where are we now? 36
MicroRNAs as new therapeutic targets and tools in cancer 36
MiR-1227 targets SEC23A to regulate the shedding of large extracellular vesicles 36
miR-550a-3p is a prognostic biomarker and exerts tumor-suppressive functions by targeting HSP90AA1 in diffuse malignant peritoneal mesothelioma 34
Photochemically enhanced delivery of a cell-penetrating peptide nucleic acid conjugate targeting human telomerase reverse transcriptase: effects on telomere status and proliferative potential of human prostate cancer cells 28
NFYA alternative cleavage and polyadenylation in cancer 23
Study of lncRNAs in Pediatric Neurological Diseases: Methods, Analysis of the State-of-Art and Possible Therapeutic Implications 22
Functional Study of the Noncoding Regulome of the Nuclear Factor Y 21
The pancancer overexpressed and cell cycle regulated NFYC antisense 1 controls tumor E2F/MYC proliferation programs through in cis and in trans modes of action 19
lncRNAs at the interplay between neurodegeneration and cancer: a role for MINCR 18
NFYC-AS1 antisense lncRNA as a potential novel player in cell cycle regulation in human cancer 18
The MYC-induced Long Non-Coding RNA MINCR as a potential novel player in cell cycle regulation in prostate cancer 16
NFYA alternative cleavage and polyadenylation in cancer 16
Computational analysis of five neurodegenerative diseases reveals shared and specific genetic loci 16
Cleavage and polyadenylation machinery as a novel targetable vulnerability for human cancer 15
NFYA alternative cleavage and polyadenylation in cancer 14
Linc00941 fuels ribogenesis and protein synthesis by supporting robust cMYC translation in Malignant Pleural Mesothelioma 12
MicroRNAs in Prostate Cancer: A Possible Role as Novel Biomarkers and Therapeutic Targets? 10
NFYC-AS1 antisense lncRNA as a potential novel player in cell cycle regulation in human cancer 9
Totale 5.939
Categoria #
all - tutte 18.953
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 18.953


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.008 0 0 45 160 79 141 119 62 179 118 67 38
2020/2021891 120 76 64 47 59 93 54 50 75 98 65 90
2021/2022685 41 49 35 47 60 30 41 57 85 70 51 119
2022/2023848 111 53 58 71 125 157 21 57 94 7 50 44
2023/20241.255 36 58 39 36 197 53 113 119 66 119 216 203
2024/2025440 176 203 61 0 0 0 0 0 0 0 0 0
Totale 5.939